News
Investor's Business Daily on MSN2d
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli LillyNovo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.
Biogen ( NASDAQ: BIIB) and City Therapeutics signed a collaboration to develop novel RNA interference ( (RNAi)) therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback